Day: November 4, 2021
Monthly information regarding the total number of voting rights and
total number of shares of the Company as of October 31, 2021
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345DateTotal number of shares
Total number of voting rights10/31/2021
55,011,687Total gross of voting rights: 55,011,687Total net* of voting rights: 54,910,187* Total net = total number of voting rights attached to shares – shares without voting rights
AttachmentPDF Version
Galecto Reports Third Quarter Operating and Financial Results
Written by Customer Service on . Posted in Public Companies.
Announces clinical collaboration with Roche for first line NSCLC
Remains on track with clinical data milestone timing
BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced its operating and financial results for the quarter ended September 30, 2021.
“The third quarter continued to show strong execution by the Galecto team, as we initiated enrollment in two separate Phase 2 trials with different mechanisms of action – one focused on our oral galectin-3 inhibitor, GB1211, for the treatment of liver cirrhosis, and the other focused on our collagen-cross linking enzyme, LOXL2, inhibitor, GB2064, for the treatment of myelofibrosis. We recently completed enrollment in Part 1 of the liver cirrhosis...
FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit
Written by Customer Service on . Posted in Public Companies.
Soft exoskeleton device for stroke survivors will be for use at home and in the community to help with walking and mobility
MARLBOROUGH, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA). The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological injuries, such as stroke. The ReBoot is a customizable personalized device intended for home and community use. It is a sister product to the ReStore device, which received...
IntelGenx to Report Third Quarter 2021 Financial Results on November 11, 2021 – Conference Call to Follow
Written by Customer Service on . Posted in Public Companies.
SAINT LAURENT, Quebec, Nov. 04, 2021 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2021 financial results after market close on Thursday, November 11, 2021.
An accompanying conference call will be hosted by Dr. Horst G. Zerbe, Chief Executive Officer, and Mr. Andre Godin, President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:Third Quarter 2021 Results Conference Call Details:
Date:
Thursday, November 11, 2021
Time:
4:30 p.m. ET
Live Call:
1-888-506-0058 (Canada and the United States)
1-973-528-0135 (International)
Access Code:
995615The call will also be broadcast live...
Mandalay Resources Provides Target Release Date for Third Quarter 2021 Financial Results and Conference Call
Written by Customer Service on . Posted in Public Companies.
TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or “the Company”) (TSX: MND, OTCQB: MNDJF) announces that its third quarter 2021 financial results will be released after market close on November 09, 2021, followed by a conference call with Dominic Duffy, President and Chief Executive Officer of Mandalay for investors and analysts on November 10, 2021, at 8:00 AM (Toronto time).
Analysts and interested investors are invited to participate using the following dial-in numbers:Participant Number (Toll free):
(800) 582-0984Participant Number:
(212) 231-2912Conference ID:
13724968A replay of the conference call will be available until 11:59 PM (Toronto time), November 24, 2021, and can be accessed using the following dial-in number:Encore Toll Free Dial-in Number:
(877) 660-6853Encore...
AgileThought Announces Third Quarter 2021 Earnings Release and Conference Call Date
Written by Customer Service on . Posted in Public Companies.
DALLAS, Nov. 04, 2021 (GLOBE NEWSWIRE) — AgileThought, Inc. (“AgileThought” or the “Company”) (NASDAQ: AGIL), a global provider of digital transformation services, custom software development, and next generation technologies, today announced that it will release its third quarter 2021 financial results after the market close on Monday, November 15, 2021. The Company will host a conference call to discuss its financial results at 5:00 p.m. Eastern Time that same day.
Those wishing to participate via webcast should access the call through the Company’s Investor Relations website at https://ir.agilethought.com/. Those wishing to participate via telephone may dial in at 1-877-407-9039 (USA) or 1-201-689-8470 (International). The conference call replay will be available via webcast through the Company’s Investor Relations website....
Host Hotels & Resorts Provides Updated Investor Presentation for Nareit’s Virtual REITworld 2021 Annual Conference (November 9-11)
Written by Customer Service on . Posted in Public Companies.
BETHESDA, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST), the nation’s largest lodging real estate investment trust (the “Company”), today provided an updated investor presentation for Nareit’s Virtual REITworld 2021 Annual Conference (November 9-11). The investor presentation can be found on the Investor Relations section on the company’s website at https://www.hosthotels.com/investor-relations/investor-presentation.
About Host Hotels & Resorts
Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 75 properties in the United States and five properties internationally totaling approximately 45,400 rooms. The Company...
Safeguard Scientifics Announces Third Quarter 2021 Financial Results
Written by Customer Service on . Posted in Public Companies.
Successful Completion of $39mm Self-tender Offer
Conference call and webcast on November 4, 2021 at 5 p.m. ET
RADNOR, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) — Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard” or the “Company”) today announced financial results for the three and nine months ended September 30, 2021.
HIGHLIGHTSCapital ReturnOn October 7, 2021, Safeguard completed a modified Dutch auction self-tender that resulted in the repurchase of 4.3 million shares of its common stock at a cost of $9.00 per share or a total of $38.7 million.Exits & DeploymentsFlashtalking was acquired by Mediaocean resulting in $44.8 million of cash proceeds upon the closing. As a result of this exit, Safeguard reported a gain of $32.3 million.
Safeguard funded $1.7 million to Aktana as part of a larger financing.Safeguard...
Doman Building Materials Group Ltd. Increases Quarterly Dividend and Announces Third Quarter 2021 Financial Results
Written by Customer Service on . Posted in Dividend Reports And Estimates.
NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATES
Q3 2021 Financial Highlights(1):Revenues increased 32.4% to $625.3 million
Gross Margin at 12.9%
Adjusted EBITDA(3) amounted to $34.5 million
Net Earnings amounted to $7.7 million
Quarterly dividend of $0.12 per share paid on October 15, 2021(4) and the Board of Directors increases quarterly dividend to $0.14 per share effective the fourth quarter of 2021VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX:DBM; DBM.NT.A) announced today its third quarter 2021 financial results(1) for the period ended September 30, 2021.
For the three-month period ended September 30, 2021(1), consolidated revenues increased by 32.4% to $625.3 million when compared to $472.2 million in the same period in 2020. The...
Cross Keys Capital Advises Retina Associates of Utah, P.C., on Its Partnership with Retina Consultants of America
Written by Customer Service on . Posted in Mergers And Acquisitions.
Fort Lauderdale, FL, Nov. 04, 2021 (GLOBE NEWSWIRE) — Cross Keys Capital, a leading investment bank to physician group practices and healthcare service and technology companies, is pleased to announce it has served as the exclusive sell-side M&A advisor to Retina Associates of Utah, P.C. (RAU), in its partnership with Retina Consultants of America (RCA), a portfolio company of Webster Equity Partners. The Cross Keys team included Jeanne Proia, Managing Director, and Patrick Foley, Senior Analyst, who both have extensive experience with retina transactions.
RAU is the largest group of retina specialists in the Intermountain West and provides comprehensive medical and surgical treatment for disorders of the retina, macula, and vitreous. The practice is led by five partner physicians and includes six board-certified and fellowship-trained...